Key result
ECG screening increases new AF detection ~76% but fails to reduce stroke or mortality.
Why the study?
ECG-based AF screening in older adults may increase detection and anticoagulation, but screening strategies, AF definitions, AF burden, and treatment thresholds vary across trials.
Does short-term or intermittent non-invasive ECG-based screening for AF increase AF detection and improve clinical outcomes in older adults without known AF?
Meta-Analysis (n=77,526)
Does short-term or intermittent non-invasive ECG-based screening for AF increase AF detection and improve clinical outcomes in older adults without known AF?
Relative Risk: 1.76 (95% CI 1.21–2.56)
p-value: p=0.003
Short-term and intermittent ECG-based AF screening in older adults increases AF detection and OAC initiation but does not significantly reduce stroke, mortality, or major bleeding, supporting a cautious, risk-based screening approach.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“While short-term and intermittent ECG-based AF screening in older adults without known AF increased AF detection, it did not improve clinical outcomes, including stroke and mortality.”
Does not support routine short-term ECG screening in older adults; leaves open whether prolonged monitoring reduces stroke or mortality.
Non-invasive ECG-based screening for atrial fibrillation (AF) in older adults may increase detection of silent AF and uptake of oral anticoagulation (OAC), but screening strategies, AF definitions, AF burden, and downstream treatment thresholds vary across trials. We performed a a GRADE-assessed meta-analysis of randomized controlled trials (RCTs) comparing short-term or intermittent non-invasive ECG-based AF screening strategies versus usual care, opportunistic detection, or no invitation in older adults without known AF. For dichotomous outcomes, pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using random-effects models. Trial sequential analysis (TSA) assessed conclusiveness of evidence. Across seven RCTs involving 77,526 participants (38,770 assigned to ECG-based screening and 38,756 to control group), screening increased new AF diagnoses compared with control (RR 1.76, 95% CI 1.21–2.56; moderate-certainty). ECG-based screening also increased new OAC initiation (RR 1.78, 95% CI 1.13–2.81; moderate-certainty). However, there were no significant differences in stroke or systemic embolism (RR 0.95, 95% CI 0.89–1.01), all-cause mortality (RR 0.98, 95% CI 0.95–1.02), or major bleeding (RR 0.98, 95% CI 0.92–1.05). Exploratory subgroup analyses by screening framework did not show statistically significant subgroup differences for AF detection, stroke/systemic embolism, mortality, or major bleeding. TSA indicated that evidence for AF detection and clinical outcomes remains inconclusive. Short-term and intermittent ECG-based AF screening in older adults without known AF increases trial-defined AF detection and OAC initiation but has not demonstrated reductions in stroke, mortality, or major bleeding. Current evidence supports a cautious, risk-based screening approach rather than broad population-wide implementation.
No takes yet. Share an insight, caveat, or question.
Rakab et al. (2026) conducted a meta-analysis in Atrial fibrillation (n=77,526). Short-term or intermittent non-invasive ECG-based screening vs. Usual care, opportunistic detection, or no invitation was evaluated on Detection of new atrial fibrillation (RR 1.76, 95% CI 1.21-2.56, p=0.003). Short-term and intermittent ECG-based screening in older adults without known AF increased new AF diagnoses (RR 1.76) and oral anticoagulation initiation, but did not reduce stroke or mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: